Variable | Baseline | |||||
---|---|---|---|---|---|---|
Overall | AB | 5ARI | CT | % Standardized difference * | ||
28273 | 24626 | 2309 | 1338 | 5ARI vs AB | CT vs AB | |
No. (%) | No. (%) | No. (%) | No. (%) | |||
Mean age (± SD) | 70.28 (9.46) | 69.55 (9.36) | 75.61 (8.72) | 74.49 (8.25) | 66.99 | 58.3 |
Age | ||||||
40–55 | 1699 (6.01) | 1641 (6.66) | 42 (1.82) | 16 (1.20) | −24.22 | −28.42 |
56–65 | 7001 (24.76) | 6579 (26.72) | 248 (10.74) | 174 (13.00) | −41.83 | −34.89 |
66–75 | 11,120 (39.33) | 9819 (39.87) | 791 (34.26) | 510 (38.12) | −11.65 | −3.6 |
76–85 | 7054 (24.95) | 5555 (22.56) | 961 (41.62) | 538 (40.21) | 41.71 | 38.75 |
>85 | 1399 (4.95) | 1032 (4.19) | 267 (11.56) | 100 (7.47) | 27.63 | 14.04 |
Previous hospitalization for BPH | 1312 (4.64) | 1048 (4.26) | 167 (7.23) | 97 (7.25) | 12.82 | 12.88 |
Previous BPH surgery | 98 (0.35) | 88 (0.36) | 7 (0.30) | 3 (0.22) | −0.94 | −2.47 |
Previous BPH severity factors | 854 (3.02) | 715 (2.90) | 95 (4.11) | 44 (3.29) | 6.58 | 2.22 |
Previous BPH related therapy | 16,491 (58.33) | 14,220 (57.74) | 1377 (59.64) | 894 (66.82) | 3.84 | 18.8 |